Dawaa Reference

chronic

Worry About a Blood or Immune Disease

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources3 sources

ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class BS90 - condition scope only, no dose · Illness Anxiety Disorder - StatPearls - NCBI Bookshelf (NBK554399) - https://www.ncbi.nlm.nih.gov/books/NBK554399/ · No dose - referral pathway, no medicine given in primary care

Verified against1 document
  • No dose - referral pathway, no medicine given in primary care

Verified date2026-08

1

NO DRUG THERAPY IN PRIMARY CARE (REFERRAL & ADVICE)

1st line
Adult dose and duration

Patient is worried about having a blood or immune disorder (e.g. leukaemia, anaemia) without one being confirmed. GP's role is a focused history, exam and appropriate screening tests, then reassurance; referral is only needed if anxiety is significant or a real abnormality turns up. - Refer, with advice

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

Patient is worried about having a blood or immune disorder (e.g. leukaemia, anaemia) without one being confirmed. GP's role is a focused history, exam and appropriate screening tests, then reassurance; referral is only needed if anxiety is significant or a real abnormality turns up.

Cautions
  • No medicine is prescribed for this in primary care - this entry is for recognition and referral. Anything given is decided by the service it is referred to.
  • RED FLAG - Objective findings on examination or blood tests (pallor, bruising, lymphadenopathy, an abnormal CBC) turn this from worry into a real diagnosis.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.